Mandrola’s Top 10 Cardiology Stories of 2019
It’s probably no surprise that ISCHEMIA and the EXCEL controversy make John Mandrola’s annual list for 2019. He also found good news in heart failure and has words of caution for TAVR expansion.
It’s probably no surprise that ISCHEMIA and the EXCEL controversy make John Mandrola’s annual list for 2019. He also found good news in heart failure and has words of caution for TAVR expansion.
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…